These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 23521217)

  • 1. Re-expression of microRNA-150 induces EBV-positive Burkitt lymphoma differentiation by modulating c-Myb in vitro.
    Chen S; Wang Z; Dai X; Pan J; Ge J; Han X; Wu Z; Zhou X; Zhao T
    Cancer Sci; 2013 Jul; 104(7):826-34. PubMed ID: 23521217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B-cell differentiation in EBV-positive Burkitt lymphoma is impaired at posttranscriptional level by miRNA-altered expression.
    Leucci E; Onnis A; Cocco M; De Falco G; Imperatore F; Giuseppina A; Costanzo V; Cerino G; Mannucci S; Cantisani R; Nyagol J; Mwanda W; Iriso R; Owang M; Schurfeld K; Bellan C; Lazzi S; Leoncini L
    Int J Cancer; 2010 Mar; 126(6):1316-26. PubMed ID: 19530237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low expression of miR-150 in pediatric intestinal Burkitt lymphoma.
    Wang M; Yang W; Li M; Li Y
    Exp Mol Pathol; 2014 Apr; 96(2):261-6. PubMed ID: 24613688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of A-myb, but not c-myb and B-myb, is restricted to Burkitt's lymphoma, sIg+ B-acute lymphoblastic leukemia, and a subset of chronic lymphocytic leukemias.
    Golay J; Luppi M; Songia S; Palvarini C; Lombardi L; Aiello A; Delia D; Lam K; Crawford DH; Biondi A; Barbui T; Rambaldi A; Introna M
    Blood; 1996 Mar; 87(5):1900-11. PubMed ID: 8634438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr Virus (EBV)-BamHI-A Rightward Transcript (BART)-6 and Cellular MicroRNA-142 Synergistically Compromise Immune Defense of Host Cells in EBV-Positive Burkitt Lymphoma.
    Zhou L; Bu Y; Liang Y; Zhang F; Zhang H; Li S
    Med Sci Monit; 2016 Oct; 22():4114-4120. PubMed ID: 27796281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomere size and telomerase activity in Epstein-Barr virus (EBV)-positive and EBV-negative Burkitt's lymphoma cell lines.
    Mochida A; Gotoh E; Senpuku H; Harada S; Kitamura R; Takahashi T; Yanagi K
    Arch Virol; 2005 Oct; 150(10):2139-50. PubMed ID: 15986178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virus-encoded microRNA contributes to the molecular profile of EBV-positive Burkitt lymphomas.
    Piccaluga PP; Navari M; De Falco G; Ambrosio MR; Lazzi S; Fuligni F; Bellan C; Rossi M; Sapienza MR; Laginestra MA; Etebari M; Rogena EA; Tumwine L; Tripodo C; Gibellini D; Consiglio J; Croce CM; Pileri SA; Leoncini L
    Oncotarget; 2016 Jan; 7(1):224-40. PubMed ID: 26325594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The F-box E3 ligase protein FBXO11 regulates EBNA3C-associated degradation of BCL6.
    Sun K; Bose D; Singh RK; Pei Y; Robertson ES
    J Virol; 2024 Jul; 98(7):e0054824. PubMed ID: 38864622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 5' regulatory sequences of active miR-146a promoters are hypomethylated and associated with euchromatic histone modification marks in B lymphoid cells.
    Szenthe K; Koroknai A; Banati F; Bathori Z; Lozsa R; Burgyan J; Wolf H; Salamon D; Nagy K; Niller HH; Minarovits J
    Biochem Biophys Res Commun; 2013 Apr; 433(4):489-95. PubMed ID: 23528241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) induces the expression of the cellular microRNA miR-146a.
    Motsch N; Pfuhl T; Mrazek J; Barth S; Grässer FA
    RNA Biol; 2007 Nov; 4(3):131-7. PubMed ID: 18347435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional role of phosphatidylinositol 3-kinase/Akt pathway on cell growth and lytic cycle of Epstein-Barr virus in the Burkitt's lymphoma cell line, P3HR-1.
    Mori T; Sairenji T
    Virus Genes; 2006 Jun; 32(3):327-34. PubMed ID: 16732486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas.
    Bellan C; Lazzi S; Hummel M; Palummo N; de Santi M; Amato T; Nyagol J; Sabattini E; Lazure T; Pileri SA; Raphael M; Stein H; Tosi P; Leoncini L
    Blood; 2005 Aug; 106(3):1031-6. PubMed ID: 15840698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virally induced cellular microRNA miR-155 plays a key role in B-cell immortalization by Epstein-Barr virus.
    Linnstaedt SD; Gottwein E; Skalsky RL; Luftig MA; Cullen BR
    J Virol; 2010 Nov; 84(22):11670-8. PubMed ID: 20844043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Piperlongumine inhibits proliferation and survival of Burkitt lymphoma in vitro.
    Han SS; Son DJ; Yun H; Kamberos NL; Janz S
    Leuk Res; 2013 Feb; 37(2):146-54. PubMed ID: 23237561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
    Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of bcl-2 in Burkitt's lymphoma cell lines: induction by latent Epstein-Barr virus genes.
    Finke J; Fritzen R; Ternes P; Trivedi P; Bross KJ; Lange W; Mertelsmann R; Dölken G
    Blood; 1992 Jul; 80(2):459-69. PubMed ID: 1378321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of BIC and microRNA miR-155 expression in primary cases of Burkitt lymphoma.
    Kluiver J; Haralambieva E; de Jong D; Blokzijl T; Jacobs S; Kroesen BJ; Poppema S; van den Berg A
    Genes Chromosomes Cancer; 2006 Feb; 45(2):147-53. PubMed ID: 16235244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tubacin kills Epstein-Barr virus (EBV)-Burkitt lymphoma cells by inducing reactive oxygen species and EBV lymphoblastoid cells by inducing apoptosis.
    Kawada J; Zou P; Mazitschek R; Bradner JE; Cohen JI
    J Biol Chem; 2009 Jun; 284(25):17102-17109. PubMed ID: 19386607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. l-Asparaginase synergizes with etoposide via the PI3K/Akt/mTOR pathway in Epstein-Barr virus-positive Burkitt lymphoma.
    Sang W; Tu D; Zhang M; Qin Y; Yin W; Song X; Sun C; Yan D; Wang X; Zeng L; Li Z; Xu K; Xu L
    J Biochem Mol Toxicol; 2022 Aug; 36(8):e23117. PubMed ID: 35757978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-focused CRISPR/Cas9 screen identifies miR-142 as a key regulator of Epstein-Barr virus reactivation.
    Chen Y; Kincaid RP; Bastin K; Fachko DN; Skalsky RL
    PLoS Pathog; 2024 Jun; 20(6):e1011970. PubMed ID: 38885264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.